Werewolf Therapeutics Inc logo

HOWL

NASDAQ

Werewolf Therapeutics Inc

Price unavailable — configure POLYGON_API_KEY

Key Statistics
Market Cap$49.08M
P/E RatioN/A
Div. Yield
EPS (TTM)-$1.33
52W High$2.38
52W Low$0.53
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees39
Price Performance
1 Week+29.35%
3 Month+56.73%
1 Year+27.43%
FinancialsAnnual · QuiverQuant
Revenue$19.94M
Assets$174.83M
Liabilities$63.46M
Net Income$37.37M loss

About

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze HOWL with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.